Queen's University
Kingston, Ontario, K7L 3N6, Canada
NCT Number: NCT03320148
This is a pilot cluster randomized controlled trial to determine the feasibility of a cluster randomized trial to evaluate the individual and health system impact of implementing a new physiotherapist-led primary care model for back pain in Canada.
Looking for future studies?
Notify Me18 year and older
All sexes
Interventional
Not applicable
Kingston, Ontario, K7L 3N6, Canada
This study aims to determine the feasibility of conducting a cluster randomized trial in primary care settings in Ontario to evaluate the individual health outcomes and health system impact of implementing a new physiotherapist-led primary care model for people with back pain. The primary purpose of this pilot study is to determine the feasibility including recruitment and retention of primary care teams (sites) and patient participants, carrying out the assessment procedures, and implementing the physiotherapist-led primary care intervention including training the physiotherapist to adopt this role.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The physician led primary care intervention will be unstandardized to best reflect standard clinical practice in Canada.
Time frame: Baseline
Ability to recruit four primary care teams (Family Health Teams or Community Health Centres) to paricipate
Time frame: Baseline to 14 weeks
Recruitment rate (participants/week) or total number of participants recruited in 14 weeks
Time frame: Baseline, 6-week 12-week, 6,9,12 month follow-up. The primary time point for this assessment is 12-week follow-up.
Percentage of all assessment items completed by participants completing each assessment
Time frame: Retention of participants at 6-week, 12-week, 6, 9, and 12-month follow-up assessments. The primary timeline for this outcome is 12-month follow-up.
Attrition rate
Time frame: Baseline
The PT will rate his/her confidence in each component of the intervention after the training on a scale from 0-10 with higher scores indicating greater confidence in carrying out that component of the intervention.
Time frame: 6-week follow-up
Treatment fidelity will be measured by consistency with the intervention described in the protocol measured through an intervention checklist completed by the physiotherapist and an audit of the EMR notes.
Time frame: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
measured using the Roland Morris Disability Questionnaire (0 to 24 with higher scores indicating greater disability)
Time frame: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
measured using a numeric pain rating scale from 0 to 10 with higher scores indicating greater pain intensity (measured at rest, during walking, and during a lifting task)
Time frame: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
measured using the EuroQoL-5D-5L (0 to 100 with greater scores indicating greater self-reported health related quality of life)
Time frame: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
measured using an 11-point scale (-5 to +5 with negative scores indicating a worsening of physical functioning related to back pain and positive scores indicating an improvement of physical functioning related to back pain)
Time frame: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
measured using an 11-point scale(-5 to +5 with negative scores indicating a dissatisfaction with health care received and positive scores indicating satisfaction with health care received)
Time frame: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
measured using the Pain Catastrophizing Scale (0 to 52 with higher scores indicating greater catastrophic thinking)
Time frame: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
measured using the 9-item Patient Health Questionnaire (PHQ-9) (0 to 27 with greater scores indicating increased depressive symptoms)
Time frame: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
measured using an adverse events questionnaire that asks 1) if the patient has experienced any adverse events as a result of the treatments received (yes/no); 2) how long the event lasted (hours or days); 3) how severe the adverse event was (0-10 scale); 4) what adverse events were experienced.
Time frame: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
Percentage of patients receiving care within 48 hours.
Time frame: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
Percentage of patients who score medium or high risk on the STarT Back tool who receive physiotherapy care.
Time frame: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
All health care visits (aggregated and dis-aggregated) including: primary care visits, emergency department visits, hospitalizations, surgeries, consultations with other health care providers, diagnostic imaging, medications, and other care received by the patient
Time frame: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
Includes all health care costs plus societal costs using a human capital approach for loss of productivity
Time frame: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
Measured as a process outcome
Time frame: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
Measured as a process outcome
Time frame: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
Measured as a process outcome
Time frame: Baseline, 6-week, 12-week, 6-month, 9-month, and 12-month follow-up
Measured as a process outcome
Queen's University
Other
Determining the Impact of a New Physiotherapist Led Primary Care Model for Back Pain: A Pilot Cluster Randomized Controlled Trial
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07292350
Back Pain, Neck Pain
Istanbul, Turkey (Türkiye)
View Trial DetailsNCT01293019
Back Pain, Chest Pain
Paris, France
View Trial DetailsNCT03680846
Back Pain, Neurologic Manifestations
Redwood City, California, United States
View Trial DetailsNCT07661082
Back Pain, Chronic Back Pain
Scottsdale, Arizona, United States
View Trial Details